Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Hematology and Cell Therapy
Published in: Hematology and Cell Therapy 4/1999

01-08-1999 | Original articles

Evaluation of hematopoietic progenitors in hematopoietic progenitor cell transplants. CD34+ dose effect in marrow recovery. Retrospective analysis in 38 patients

Authors: R. Gabús, A. Magariños, M. Zamora, E. De Lisa, A.I. Landoni, G. Martínez, C. Canessa, H. Giordano, E. Bodega

Published in: Hematology and Cell Therapy | Issue 4/1999

Login to get access
Metadata
Title
Evaluation of hematopoietic progenitors in hematopoietic progenitor cell transplants. CD34+ dose effect in marrow recovery. Retrospective analysis in 38 patients
Authors
R. Gabús
A. Magariños
M. Zamora
E. De Lisa
A.I. Landoni
G. Martínez
C. Canessa
H. Giordano
E. Bodega
Publication date
01-08-1999
Publisher
Springer-Verlag
Published in
Hematology and Cell Therapy / Issue 4/1999
Print ISSN: 1269-3286
Electronic ISSN: 1279-8509
DOI
https://doi.org/10.1007/s00282-999-0171-y

Other articles of this Issue 4/1999

Hematology and Cell Therapy 4/1999 Go to the issue

Original articles

Contributions of p53 and PMA to g-irradiation induced apoptosis in Jurkat cells

Original articles

Progressive multifocal leukoencephalitis (PML) in three patients treated with standard-dose fludarabine (FAMP)

Review articles

Infectious complications in chronic lymphocytic leukaemia

Original articles

Megakaryocytopoiesis in refractory chronic immune thrombocytopenia

Original articles

Molecular basis to understand polyploidy

Case reports

Sinus polyp-associated soft tissue lesion and unilateral blindness: complications of extraction in leukemic patient
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits